Kernel is a Non-Invasive Neuroimaging company founded in 2016 and based in Los Angeles, United States. It has raised $53M in total funding, most recently a Series C in 2020.
| Date | Stage | Amount | Valuation | Lead investors |
|---|---|---|---|---|
| Jul 9, 2020 | Series C | $53M | — | General Catalyst |
No articles ingested yet for Kernel. Once the hourly news pipeline is live, every article the classifier tags as mentioning this company appears here with its one-line AI summary and sentiment.
A wearable time-domain functional near-infrared spectroscopy (TD-fNIRS) helmet containing 52 sensor modules that measures cortical hemodynamics and blood-oxygenation patterns in real time. Weighing ~2 kg, it allows subjects to remain ambulatory during recording sessions. Deployed in academic cognitive-neuroscience studies, psychedelic drug trials, and longevity-clinic applications where conventional MRI is impractical.
A suite of wellness-oriented brain-health tracking products launched in 2025 for longevity clinics, designed to make continuous neuroimaging data accessible outside research settings. Extends Kernel's non-invasive neuroimaging platform toward consumer-grade longitudinal brain monitoring and AI-assisted brain-health analysis.